bn 52205 has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colotta, F; Diomede, L; Modest, EJ; Piovani, B; Principe, P; Re, F; Salmona, M | 1 |
1 other study(ies) available for bn 52205 and Leukemia
| Article | Year |
|---|---|
The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells.
Topics: Antineoplastic Agents; Apoptosis; Cytotoxins; DNA Damage; Humans; In Vitro Techniques; Leukemia; Lysophospholipids; Phosphatidic Acids; Tumor Cells, Cultured | 1994 |